Table 2.
Immunogenicity to HPV Vaccine
| HPV genotype | % Seropositivity * | 95% CI § | cLIA GMT mMu/ml † (95% CI) |
|---|---|---|---|
| Anti-HPV 6 |
94.4 |
(72.7, 99.9) |
427.0 (203.4, 903.4) |
| Anti-HPV 11 |
100 |
(81.5, 100) |
596.7 (303.6, 1173.2) |
| Anti-HPV 16 |
100 |
(81.5, 100) |
2263.2 (1019.3, 5024.8) |
| Anti-HPV 18 | 94.4 | (72.7, 99.9) | 331.9 (159.8, 689.2) |
*Seropositivity and anti-HPV values were determined in the 16 patients who completed the vaccine HPV series and had both pre- and post-vaccination serum available for HPV antibody measurement.
§ CI = Confidence Interval.
†cLIA GMT mMu = Competitive Luminex immunoassay, Geometric Mean Titers measured in milli-Merck units.